04/22/2024
3:07 PM | Cara Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:08 PM | Cara Therapeutics (Filer)
| Form DEFA14A | |
04/12/2024
3:15 PM | Cara Therapeutics (Filer)
Cara Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024
3:21 PM | Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:22 PM | Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:16 PM | Cara Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:24 PM | Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/04/2024
3:13 PM | Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:19 PM | Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:50 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by)
Cara Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
4:10 PM | Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:13 PM | Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:15 PM | Cara Therapeutics (Issuer)
Maynard Ryan D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:16 PM | Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:32 PM | Cara Therapeutics (Issuer)
Maynard Ryan D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:34 PM | Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:59 PM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
3:19 PM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
6:10 AM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:37 PM | Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
6:10 AM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
4:19 PM | Boudreau Helen M (Reporting)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/04/2023
4:20 PM | Boudreau Helen M (Reporting)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
4:21 PM | Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
6:06 AM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
3:07 PM | Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
3:08 PM | Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
3:09 PM | Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
